Group One Trading
CARM

Group One Trading’s Carisma Therapeutics CARM Stock Holding History

Group One Trading’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-62,300
Closed -$183K – 7106
2023
Q4 		$183K Sell
62,300
-18,300
-23% -$54.4K ﹤0.01% 3949
2023
Q3 		$341K Sell
80,600
-12,200
-13% -$77.2K ﹤0.01% 3305
2023
Q2 		$814K Sell
92,800
-110,900
-54% -$604K ﹤0.01% 2547
2023
Q1 		$631K Buy
203,700
+183,570
+912% +$1.75M ﹤0.01% 2545
2022
Q4 		$245K Sell
20,130
-7,205
-26% -$75.7K ﹤0.01% 3689
2022
Q3 		$232K Buy
27,335
+740
+3% +$10.1K ﹤0.01% 3989
2022
Q2 		$431K Sell
26,595
-4,290
-14% -$49.1K ﹤0.01% 3571
2022
Q1 		$372K Buy
30,885
+2,105
+7% +$29.4K ﹤0.01% 4139
2021
Q4 		$469K Sell
28,780
-30,205
-51% -$608K ﹤0.01% 4200
2021
Q3 		$936K Buy
58,985
+41,795
+243% +$2.01M ﹤0.01% 3485
2021
Q2 		$1.59M Buy
17,190
+10,350
+151% +$660K ﹤0.01% 2889
2021
Q1 		$356K Buy
6,840
+5,775
+542% +$272K ﹤0.01% 4420
2020
Q4 		$29K Sell
1,065
-10,285
-91% -$261K ﹤0.01% 5312
2020
Q3 		$318K Buy
11,350
+7,275
+179% +$146K ﹤0.01% 3264
2020
Q2 		$59K Buy
+4,075
New +$55K ﹤0.01% 4252
2020
Q1 		– Sell
-1,485
Closed -$31K – 5289
2019
Q4 		$31K Sell
1,485
-65
-4% -$1.49K ﹤0.01% 4207
2019
Q3 		$36K Buy
1,550
+310
+25% +$7.25K ﹤0.01% 4130
2019
Q2 		$37K Sell
1,240
-465
-27% -$13.9K ﹤0.01% 3921
2019
Q1 		$35K Buy
1,705
+140
+9% +$2.42K ﹤0.01% 3745
2018
Q4 		$44K Sell
1,565
-5,360
-77% -$171K ﹤0.01% 3622
2018
Q3 		$298K Sell
6,925
-985
-12% -$38.4K ﹤0.01% 2709
2018
Q2 		$308K Buy
+7,910
New +$349K ﹤0.01% 2701

Other funds holding CARM

MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $15.7B AUM 34.02% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
OP
ORG Partners Roanoke, Indiana $568M AUM 24.16% 1-Year Est. Return

Group One Trading's CARM Position: Q4 2025 in Review

Group One Trading sold out of Carisma Therapeutics (CARM) in Q4 2025, closing a stake of 2,230 shares — an estimated $611 sold.

Group One Trading first reported a position in CARM in Q4 2015 and held it in 31 quarters. The position peaked at $641K in Q4 2021. 7 funds tracked by Wall St. Rank hold CARM as of Q4 2025.

  • Group One Trading reported no remaining Carisma Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 2,230 Carisma Therapeutics shares in Q4 2025, an estimated $611.
  • Group One Trading first reported a position in Carisma Therapeutics in Q4 2015 and held it in 31 quarters.
  • Group One Trading's Carisma Therapeutics position peaked at $641K in Q4 2021.
  • 7 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.